What percentage of women test positive during pregnancy for Glucose Tolerance (GT) screening test, also known as Oral Glucose Tolerance Test (OGTT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Approximately 15-20% of pregnant women test positive during the initial glucose tolerance screening test. This screening, typically performed between 24-28 weeks of pregnancy, involves drinking a glucose solution and having blood drawn an hour later to measure blood sugar levels. A positive result (usually defined as a blood glucose level of 140 mg/dL or higher) doesn't necessarily mean the woman has gestational diabetes; rather, it indicates the need for a follow-up diagnostic test called the oral glucose tolerance test (OGTT) 1. Of those who test positive on the initial screening, only about one-third will actually be diagnosed with gestational diabetes after the confirmatory OGTT. The screening test has intentionally high sensitivity to minimize missed cases, which explains the relatively high rate of positive results. Factors that increase the likelihood of a positive screening include:

  • Advanced maternal age
  • Obesity
  • Family history of diabetes
  • Previous gestational diabetes
  • Certain ethnic backgrounds with higher diabetes risk 1. The prevalence of gestational diabetes mellitus (GDM) in the United States is about 6% to 7%, affecting approximately 240,000 of 4 million annual births 1. The diagnosis of GDM is made when any of the following plasma glucose values are exceeded: fasting ≥ 92 mg/dL, 1 hour ≥ 180 mg/dL, or 2 hours ≥ 153 mg/dL 1.

From the Research

Prevalence of Gestational Diabetes Mellitus

  • The prevalence of gestational diabetes mellitus (GDM) varies across studies and diagnostic criteria, ranging from 2 to 50 percent 2.
  • According to the American Diabetes Association (75 g) criteria, the prevalence of GDM is between 2 and 19 percent 2.
  • The Carpenter and Coustan criteria report a prevalence of 3.6 to 38 percent, while the National Diabetes Data Group criteria show a range of 1.4 to 50 percent 2.
  • The World Health Organization criteria indicate a prevalence of 2 to 24.5 percent 2.

Screening and Diagnosis of GDM

  • A two-step approach (1-hour 50 g glucose challenge test followed by 3-hour 100 g oral glucose tolerance test) has been widely used for GDM screening and diagnosis 3.
  • A one-step approach (75 g oral glucose tolerance test) is also recommended as an option for the diagnosis of GDM after 2010 3.
  • The 50 g oral glucose challenge test with a glucose threshold of 130 mg/dL versus 140 mg/dL improves sensitivity and reduces specificity 2.

Percentage of Women Testing Positive

  • The exact percentage of women testing positive during pregnancy glucose tolerance screening test is not directly stated in the provided studies.
  • However, the studies suggest that the prevalence of GDM varies widely depending on the diagnostic criteria used, ranging from 2 to 50 percent 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Screening and diagnosing gestational diabetes mellitus.

Evidence report/technology assessment, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.